About This Fund
Miura Fund IV is the fourth flagship buyout fund of Miura Partners, a Barcelona-based private equity firm founded in 2007 by Luis Seguí and Juan Leach. The fund closed at its hard cap of €475 million in September 2024 — 44% larger than its predecessor Miura Fund III (€330 million) — and received commitments from institutional investors across Europe, North America, and Asia, including over €259 million from new entrants to the Miura platform. The fund is registered with Spain's CNMV (Comisión Nacional del Mercado de Valores) as Miura Fund IV, FCR (Fondo de Capital Riesgo), with Banco Inversis as depository.
Miura Fund IV pursues control-oriented mid-market buyouts in Spain and Portugal, targeting established family-owned businesses and SMEs in niche sectors with defensible market positions. Equity investments typically range from €20 to €50 million per company, with co-investment opportunities available for larger transactions. Value creation is pursued through three core levers: consolidation of fragmented industry sectors through strategic acquisitions, internationalization of Iberian market leaders into broader European markets, and organic operational improvement initiatives. Target sectors include healthcare services, education, specialized business services, consumer goods, agri-food, industrial niches, and hospitality — areas where Miura has built deep expertise and a proven track record across 16 years of investing in Southern Europe.
Miura Partners manages over €1.5 billion in assets across all strategies and has completed more than 70 investments since its first fund in 2008, representing over €3 billion in total transaction value. Fund IV's initial investments included Serpis-Cándido Miró, a Spanish leader in branded and unbranded olive distribution, and Proclinic Group, the leading specialized dental supply distributor across Spain and Europe — exemplifying the fund's strategy of consolidating and scaling niche market leaders. In 2024, Miura raised over €800 million across three strategies (Fund IV, the Miura Impact Fund, and Dent&Co continuation vehicle), cementing its position as one of Southern Europe's most active and institutionally recognized private equity managers.